Ullistat acetate is a progesterone agonist/antagonist that inhibits or delays ovulation. However, changes in the endometrium may also be a contributing factor. CAS number is 126784-99-4, molecular formula is C30H37NO4.

Market Analysis and Insights: Global Ulipristal Acetate Market
The global Ulipristal Acetate market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Ulipristal Acetate Scope and Market Size
The global Ulipristal Acetate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ulipristal Acetate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Purity≥98%
Purity≥99%

Segment by Application
Ulipristal Acetate Tablets
Other

The Ulipristal Acetate market is analysed and market size information is provided by regions (countries). Segment by Application, the Ulipristal Acetate market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
NewChem
Maiden Group
Hangzhou Think Chemical
Shanghai Acebright
Tapi Teva
Narri
Nanjing Bold Chemical
Symbiotec
Sai Phytoceuticals
Chengdu D-Innovation Pharmaceutical
Shanghai Biliante Bio-Pharmaceutical